Oppenheimer Hld Stock Price, News & Analysis

Oppenheimer & Co. Inc. has appointed Joel Sendek as Managing Director and Head of Healthcare Life Sciences Equity Research, bolstering its research team amid evolving industry opportunities. Sendek, with extensive experience as a biotech analyst and CFO at several companies, joins to provide enhanced insights for investors in biotechnology and pharmaceuticals. His leadership aims to meet growing investor demand for informed analysis in this critical sector, as emphasized by executives John Parks and Michael Margolis during the announcement.

Oppenheimer & Co. Inc. has appointed Brad Watkins as Chief Financial Officer, effective August 1, 2022. With extensive experience in the financial services sector, notably at KPMG, Watkins will oversee Oppenheimer's financial operations and long-term budget planning. He joins at a pivotal time for the firm, which aims to enhance its operating model and drive growth. Chairman and CEO Albert G. Lowenthal emphasizes Watkins' expertise will be crucial as the company navigates an evolving market landscape.

Oppenheimer Holdings has authorized a new share repurchase program allowing the buyback of up to 536,500 shares of its Class A non-voting common stock, which is approximately 4.8% of its total outstanding shares. This program supplements the previous authorization still in effect, bringing the total to 540,778 shares available for repurchase. The purchases will be conducted in the open market at prevailing prices using available cash, contributing positively to shareholder value as all acquired shares will be canceled.

Oppenheimer Holdings Inc. reported a net loss of $3.9 million or $(0.32) EPS for Q2 2022, down from a profit of $31.2 million or $2.46 EPS in Q2 2021. Revenue decreased 30.3% to $237.2 million from $340.3 million year-over-year, primarily due to a significant downturn in equity capital market activity. Wealth Management performed relatively well, but overall metrics were affected by high inflation and rising interest rates. The firm repurchased 885,230 shares during the quarter, maintaining strong capital levels despite the loss.

Oppenheimer & Co. Inc. hosts its 22nd Annual Consumer Growth and E-Commerce Conference on June 14-15, 2022, engaging key players across consumer sectors with investors. Notable participants include Ulta Beauty and Wyndham Hotels. The conference addresses current inflation and consumer spending trends, with Oppenheimer's experts emphasizing the importance of navigating a changing economic backdrop. With many consumer companies reporting earnings declines, the event serves as a platform for discussing recovery strategies and leveraging e-commerce technologies in a volatile landscape.

Oppenheimer & Co. Inc. has appointed John C. Putrino as Co-Head of Real Estate Investment Banking and Head of Lodging & Leisure Investment Banking, enhancing its Financial Institutions team. Mr. Putrino brings over 30 years of experience, having closed 50 transactions at Janney Montgomery Scott, strengthening Oppenheimer's position in these sectors. The firm reported a substantial increase in investment banking revenue, reaching $435.9 million in 2021, a 96.1% rise from 2020, supporting its strategy to expand in strategic advisory services and capital markets solutions.

Oppenheimer Holdings announced a new share repurchase program, allowing the purchase of up to 550,000 shares of its Class A non-voting common stock, which is about 4.6% of its total outstanding shares. This adds to the 71,893 shares left from a previous buyback program, bringing the total to 621,893 shares now authorized for repurchase. The purchases will be made at market prices using available cash and will be canceled post-buyback. Timing and amounts will depend on market conditions and management's discretion.

Oppenheimer & Co. Inc. has appointed David Fleming as Managing Director of Investments and Branch Manager for its San Francisco office. With over 25 years of experience in financial advisory, he aims to enhance Oppenheimer's presence in the Bay Area. His prior roles include significant positions at Stifel and Barclays. This appointment follows Oppenheimer's strategic moves in 2022, including launching a new wealth management platform and expanding its offices. Fleming expressed enthusiasm for joining the firm and contributing to its growth.

Oppenheimer announced the appointment of Paul Clemente as Executive Director of Investments and Regional Manager for Eastern Pennsylvania, managing the Haddon Township office. With over 28 years in financial services, Clemente aims to enhance the firm's regional presence, overseeing 40 advisors managing approximately $3.1 billion in client assets. His appointment aligns with Oppenheimer's recent strategic moves, including the launch of a wealth management platform and opening a new office in Nashville.